
An innovative inhaler for patients with asthma developed by Chippenham-based specialist drug firm Vectura has secured its first approval in Latin America. The green light from Mexico’s Health Authority follows similar go-aheads in four European countries and South Korea for the AirFluSal Forspiro device, pictured, which can also be used to treat chronic obstructive...